IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)            

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Statistical Study of Some Anti-Hypertensive Drugs

Author: DR.AMIR M.SHUMRAN, DHULFIQAR A.ABED, FAIDH Y.AHMED
Abstract: Background: Hypertension is a heterogeneous disorder resulting from either a specific cause (secondary hypertension) or some underlying pathophysiologic alterations of unknown cause (essential, idiopathic, or primary hypertension). This research was designed to evaluate some of the antihypertension drugs in the Babylon province community and find a good product with high therapeutic effectiveness and lowest side effect as possible. Patients and methods: We started a survey which included all patients with hypertension (HTN), that use different drugs and also how to use their medication properly, gaining these information help us to find the best. Furthermore, we collect different cases from hospitals and clinical departments through a survey that depends on the number of volunteers and the benefits of the drug used. Results and discussion: Results showed that hypertensive females were 56% of all cases and males have 44%. Amlodipine was the most common drug of choice (54.96%), lisinopril (19.86%), valsartan (8.6%), losartan (6.6%), bisoproplol (6.6%), and Candesartan (3.3%). Actavis represent (31.325%), Acino (22.89%), Atlantic pharma (14.47%), Novartis represent (13.25%), Micro (10.84%), Bristol (4.814%), and T&D (2.409%), these results may be explained according to the effectiveness of the drug and the company, and also the economic income of most of the hypertensive patients of this research. Conclusions: According to the results of this research, amlodipine is the drug of choice, and Actavis is the preferred company in our community.
Keyword: Hypertension, heterogeneous disorder, hypertensive drugs.
DOI: https://doi.org/10.31838/ijpr/2021.13.02.070
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free